A Chemo-Genomic Approach Identifies Diverse Epigenetic Therapeutic Vulnerabilities in MYCN-Amplified Neuroblastoma

Although a rare disease, neuroblastoma accounts for the highest proportion of childhood cancer deaths. There is a lack of recurrent somatic mutations in neuroblastoma embryonal tumours, suggesting a possible role for epigenetic alterations in driving this cancer. While an increasing number of report...

Descripción completa

Detalles Bibliográficos
Autores principales: Krstic, Aleksandar, Konietzny, Anja, Halasz, Melinda, Cain, Peter, Oppermann, Udo, Kolch, Walter, Duffy, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097097/
https://www.ncbi.nlm.nih.gov/pubmed/33968920
http://dx.doi.org/10.3389/fcell.2021.612518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097097/
https://www.ncbi.nlm.nih.gov/pubmed/33968920
http://dx.doi.org/10.3389/fcell.2021.612518

Ejemplares similares